Latest Breaking News On - Thomas tam hoang - Page 1 : vimarsana.com

New data supported the safety and efficacy of nonmedical switching from infliximab to a biosimilar, according to researchers.

United kingdomBritish columbiaThomas tam hoangLaura targownikUniversity of toronto temerty faculty medicineCentre of british columbiaJournal of the canadian association gastroenterologyHealth canadaUniversity of british columbia faculty medicineBritish columbia facultyMedscape medicalCanadian associationMedscape medical newsMount sinai hospitalTemerty facultyInflammatory bowel disease ibd